HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

CTI Acquires Mirada Solutions

By HospiMedica staff writers
Posted on 12 Sep 2003
Print article
In a move to enhance the company's positron emission tomography (PET) systems, CTI Molecular Imaging, Inc. (Knoxville, TN, USA) has acquired Mirada Solutions Limited (Oxford, UK). Terms were not disclosed.

Mirada, a spinoff from Oxford University, is a developer of fusion software applications for medical imaging workstations. CTI plans to incorporate Mirada's image analysis and fusion software into all its PET scanner workstations, to enhance the analytical and diagnostic capabilities of its PET systems. Mirada has developed several products designed to provide better detection, diagnosis, and disease management through the application of image analysis software to medical images.

"We believe that we have acquired the best-in-class capability that will further distinguish our PET scanners in the marketplace,” said Terry Douglas, chairman and CEO of CTI. "With this acquisition, we not only offer the fastest scan time through our proprietary LSO technology, but we also provide the greatest level of PET image functionality for the clinician.”





Related Links:
CTI
Mirada
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Bone Marrow Biopsy Needle
BEST-LISAS
New
Mobile Patient Lift
Golvo 9000

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more